Inhibits Nrf2 signaling in human squamous carcinoma cells [77]Depletes intracellular GSH level and SOD2 in prostate cancer cells [97]Inhibits NFκB activation in human non-small lung cancer cells [176], pancreatic [177] and gastric cancer cells [178]. Here, NFE2L2 is linked to prostate carcinoma.